I don't think he meant it this way:
Although the company is relatively small in size, it has demonstrated an ability to drive strong top-line growth by acquiring China Medstar in 2008 and partnering with an increasing number of specialty cancer hospitals, with 83 centers currently in its network and another 30 in its pipeline. Concord Medical has boosted its revenue by more than four times since 2006, reaching $40 million in the last twelve months and has achieved impressive 60% operating margins.
Going forward, the company expects to benefit from increasing demand for cancer treatment, China's recent proposal to raise healthcare expenditures, and a fragmented market that provides room for further growth.
